Huadong Medicine Co., Ltd (SHE:000963)
China · Delayed Price · Currency is CNY 27.26
-0.40 (-1.45%)
Aug 31, 2026, 3:04 PM CST
Huadong Medicine Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 5,605 | 4,978 | 5,276 | 4,663 | 3,996 | 4,032 |
Short-Term Investments | - | 75.46 | - | - | - | - |
Cash & Short-Term Investments | 5,605 | 5,054 | 5,276 | 4,663 | 3,996 | 4,032 |
Cash Growth | 8.62% | -4.23% | 13.15% | 16.69% | -0.90% | 26.09% |
Accounts Receivable | 9,716 | 9,452 | 10,114 | 8,896 | 8,210 | 6,940 |
Other Receivables | 640.81 | 518.44 | 402.96 | 291.14 | 284.18 | 223.92 |
Receivables | 10,357 | 9,971 | 10,517 | 9,188 | 8,494 | 7,164 |
Inventory | 5,031 | 5,536 | 4,776 | 4,290 | 4,495 | 3,975 |
Prepaid Expenses | - | - | - | 15.07 | - | - |
Other Current Assets | 621.2 | 667.24 | 482.3 | 340.46 | 582.21 | 316.04 |
Total Current Assets | 21,614 | 21,227 | 21,052 | 18,497 | 17,568 | 15,487 |
Property, Plant & Equipment | 5,477 | 5,473 | 5,409 | 5,204 | 5,021 | 4,813 |
Long-Term Investments | 2,325 | 2,190 | 2,147 | 2,101 | 2,020 | 1,243 |
Goodwill | 2,840 | 2,860 | 2,913 | 2,599 | 2,441 | 2,139 |
Other Intangible Assets | 3,799 | 3,850 | 3,645 | 2,334 | 2,280 | 2,233 |
Long-Term Deferred Tax Assets | 439.47 | 385.08 | 221.85 | 187.81 | 152.84 | 143.65 |
Long-Term Deferred Charges | 2,136 | 1,777 | 1,056 | 1,013 | 657.81 | 12.43 |
Other Long-Term Assets | 1,345 | 1,276 | 1,436 | 1,574 | 1,051 | 925.63 |
Total Assets | 39,975 | 39,038 | 37,879 | 33,509 | 31,192 | 26,996 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 8,312 | 7,970 | 7,044 | 6,102 | 5,902 | 4,520 |
Accrued Expenses | 409.49 | 559.53 | 650.63 | 554.92 | 518.92 | 920.63 |
Short-Term Debt | 1,785 | 1,675 | 2,665 | 1,197 | 1,337 | 1,627 |
Current Portion of Long-Term Debt | 20.81 | 37.1 | 212.41 | 80.92 | 36.9 | 174.18 |
Current Portion of Leases | 51.39 | 69.19 | 67.3 | 81.98 | 75.29 | 66.86 |
Current Income Taxes Payable | 170.98 | 365.9 | 370.26 | 259.27 | 154.95 | 261.24 |
Current Unearned Revenue | 146.24 | 189.35 | 174.72 | 136.85 | 147.64 | 119.49 |
Other Current Liabilities | 2,534 | 2,225 | 2,610 | 2,389 | 1,979 | 1,576 |
Total Current Liabilities | 13,430 | 13,091 | 13,794 | 10,803 | 10,153 | 9,266 |
Long-Term Debt | 250.1 | 252.03 | 14.26 | 520.76 | 1,051 | 139.18 |
Long-Term Leases | 116.99 | 88.81 | 71.86 | 56.7 | 84.61 | 80.89 |
Long-Term Unearned Revenue | 182.12 | 190.94 | 183.86 | 171.06 | 126.12 | 83.52 |
Long-Term Deferred Tax Liabilities | 212.33 | 223.96 | 197.38 | 184.37 | 202.08 | 184.91 |
Other Long-Term Liabilities | 4.02 | 20.62 | 53.7 | 191.61 | 398.67 | 300.99 |
Total Liabilities | 14,195 | 13,867 | 14,315 | 11,927 | 12,016 | 10,055 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 1,754 | 1,754 | 1,754 | 1,754 | 1,754 | 1,750 |
Additional Paid-In Capital | 2,405 | 2,416 | 2,551 | 2,446 | 2,378 | 2,230 |
Retained Earnings | 21,477 | 20,635 | 18,852 | 16,972 | 14,639 | 12,647 |
Treasury Stock | - | - | -46.8 | -84.52 | -104.65 | - |
Comprehensive Income & Other | -194.46 | 5.77 | -50.6 | -40.34 | -88.55 | -47.77 |
Total Common Equity | 25,441 | 24,811 | 23,060 | 21,048 | 18,578 | 16,579 |
Minority Interest | 338.8 | 359.67 | 503.7 | 534.65 | 598.52 | 361.94 |
Shareholders' Equity | 25,780 | 25,171 | 23,564 | 21,582 | 19,176 | 16,941 |
Total Liabilities & Equity | 39,975 | 39,038 | 37,879 | 33,509 | 31,192 | 26,996 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 2,224 | 2,122 | 3,031 | 1,938 | 2,586 | 2,089 |
Net Cash (Debt) | 3,381 | 2,931 | 2,246 | 2,726 | 1,411 | 1,944 |
Net Cash Growth | 40.15% | 30.53% | -17.61% | 93.21% | -27.43% | 62.16% |
Net Cash Per Share | 1.93 | 1.67 | 1.28 | 1.56 | 0.81 | 1.11 |
Filing Date Shares Outstanding | 1,754 | 1,754 | 1,759 | 1,752 | 1,750 | 1,750 |
Total Common Shares Outstanding | 1,754 | 1,754 | 1,759 | 1,752 | 1,750 | 1,750 |
Working Capital | 8,184 | 8,137 | 7,258 | 7,694 | 7,415 | 6,221 |
Book Value Per Share | 14.51 | 14.15 | 13.11 | 12.01 | 10.62 | 9.47 |
Tangible Book Value | 18,803 | 18,102 | 16,502 | 16,115 | 13,856 | 12,207 |
Tangible Book Value Per Share | 10.72 | 10.32 | 9.38 | 9.20 | 7.92 | 6.98 |
Buildings | 2,596 | 2,610 | 2,483 | 2,299 | 1,865 | 1,503 |
Machinery | 5,402 | 5,355 | 5,010 | 4,438 | 4,282 | 3,385 |
Construction In Progress | 987.62 | 832.43 | 836.74 | 913.15 | 873.16 | 1,582 |